成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 1622848-92-3 Chemical Structure| 1622848-92-3

Structure of GSK2982772
CAS No.: 1622848-92-3

Chemical Structure| 1622848-92-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 1622848-92-3

,{[proInfo.pro_purity]}

GSK2982772 is an inhibitor of receptor interacting protein 1 (RIP1) with IC50 of 16 nM and it is used for the treatment of inflammatory diseases.

Synonyms: GSK2982772

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GSK2982772

CAS No. :1622848-92-3
Formula : C20H19N5O3
M.W : 377.40
SMILES Code : O=C(C1=NC(CC2=CC=CC=C2)=NN1)N[C@@H]3C(N(C)C4=CC=CC=C4OC3)=O
Synonyms :
GSK2982772
MDL No. :MFCD30828708
InChI Key :LYPAFUINURXJSG-AWEZNQCLSA-N
Pubchem ID :77108121

Safety of GSK2982772

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GSK2982772

pyroptosis

Isoform Comparison

Biological Activity

Target
  • TNF-α

    human RIP1, IC50:16 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
SK-HEP-1 cells 20 μM 24 hours Evaluate the effect of GSK2982772 on sulfasalazine-induced decrease in cell viability, results showed GSK2982772 failed to prevent the decrease in cell viability PMC8469492
Huh7 cells 20 μM 24 hours Evaluate the effect of GSK2982772 on sulfasalazine-induced decrease in cell viability, results showed GSK2982772 failed to prevent the decrease in cell viability PMC8469492

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C3H/HeN mice Alopecia areata model Intraperitoneal injection 3 mg/kg Daily for 9 weeks GSK2982772 reduced the number of AA-affected mice in the model, decreased the numbers of CD8+T cells and dendritic cells in the skin, and reduced the expression of IL-15 and IFN-γ. PMC11855397
Mice AAV-TAUP301L tauopathy model Intraperitoneal injection 2.5 mg/kg Once daily for 3 weeks To evaluate the potential therapeutic effects of GSK2982772 in reducing TAU-related astrogliosis and neurodegeneration. Results showed that GSK2982772 treatment effectively reduced the reactive astrocyte response triggered by TAUP301L overexpression but failed to protect against the neurodegeneration caused by elevated TAUP301L levels in the hippocampal region. PMC11808139

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.65mL

0.53mL

0.26mL

13.25mL

2.65mL

1.32mL

26.50mL

5.30mL

2.65mL

References

 

Historical Records

Categories